Your browser doesn't support javascript.
loading
Hyperoxia combined with the B-cell antagonist rituximab led to intestinal dysbiosis in neonatal mice.
Yang, Kun; Xu, Ya-Ji; He, Yan; Duan, Cheng-Xin; Wang, Huai-Fu; Ding, Wei-Jun.
Affiliation
  • Yang K; Department of Fundamental Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Xu YJ; Department of Fundamental Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • He Y; School of Preclinical Medicine, Department of Preclinical Medicine, Chengdu University, Chengdu, China.
  • Duan CX; Department of Fundamental Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Wang HF; Department of Fundamental Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Ding WJ; Department of Fundamental Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Microbiol Immunol ; 66(7): 353-360, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35524491
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hyperoxia / Dysbiosis Limits: Animals / Pregnancy Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hyperoxia / Dysbiosis Limits: Animals / Pregnancy Language: En Year: 2022 Type: Article